189831-00-3

Upstream product

• 5227-09-8 (+/-)-cis-1,2-Dimethoxy-4-(2-nitrocyclohex-4-enyl)benzene 

Downstream Products

• 933733-10-9 (-)-cis-1,2-dimethoxy-4-(2-amino-cyclohexyl)benzene 

Relevant academic research and scientific papers

Novel 6-heteroarylphenanthridines

Compounds of the formula I, in which Het is an unsubstituted or R6-and/or R7-sustituted pyrrolyl, furanyl, thiophenyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrimidinyl, pyrazinyl or pyridazinyl radical, or an

Phenanthridine-n-oxides

N-oxides of the compounds of formula (I) in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy or completely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy

Phenanthridine-N-oxides with PDE-IV inhibiting activity

The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel active bronchial therapeutics.

Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity

Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel active bronchial therapeutics.

Phenanthridine-n-oxides with pde-iv inhibiting activity

The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, arm novel active bronchial therapeutics.

Tetrazole derivatives

Compounds of formula I, in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are efficacious bronchial therapeutics.

6-arylphenanthridines with PDE-IV inhibiting activity

Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and Ar have the meanings indicated in the description, are novel active bronchial therapeutics.

Phenylphennanthridines with PDE-IV inhibiting activity

Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51, R6, R13 and R20 have the meaning indicated in the description, are novel active bronchial therapeutics

Phenanthridines

Compounds of formula (I), where R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings given in the description, are new active bronchial therapeutic agents.

Substituted 6-phenylphenanthridines

PCT No. PCT/EP98/04478 Sec. 371 Date Jan. 24, 2000 Sec. 102(e) Date Jan. 24, 2000 PCT Filed Jul. 18, 1998 PCT Pub. No. WO99/05113 PCT Pub. Date Feb. 4, 1999The invention relates to compounds of formula (I): wherein R1, R2, R3, R31, R4, R5, R51 and R6 are